The economics of febrile neutropenia: implications for the use of colony-stimulating factors.

@article{Lyman1998TheEO,
  title={The economics of febrile neutropenia: implications for the use of colony-stimulating factors.},
  author={Gary H. Lyman and Nicole M. Kuderer and James G. Greene and Lodovicco Balducci},
  journal={European journal of cancer},
  year={1998},
  volume={34 12},
  pages={1857-64}
}
The occurrence of fever and neutropenia following cancer chemotherapy generally prompts hospitalisation for evaluation and treatment. Colony-stimulating factors (CSFs) have been shown to reduce the risk of febrile neutropenia (FN) and the need for hospitalisation in such patients. This study was undertaken to obtain estimates of the actual institutional… CONTINUE READING